| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |